Navigation Links
Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
Date:1/8/2012

SAN DIEGO, Jan. 8, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced highlights of the Company's 2011 performance and accomplishments, as well as preliminary activities and goals for the first part of 2012.

Initial 2011 Performance Results

  • Total revenue growth of approximately 23 percent year-over-year for 2011 (unaudited).
  • Over 21,000 total prenatal and retinal diagnostic tests were billed during the year.
  • Sales in the Genetic Analysis business segment were up approximately 6 percent from 2010. (unaudited), each quarter improving over the same period in the prior year.
  • Positive results following the October 2011 launch of Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 laboratory developed test (LDT):
    • The MaterniT21 LDT is now available for sale through Sequenom CMM in all 50 states in the U.S., including New York.
    • The Company received its first payments as an out-of-network provider from major commercial payors within the first billing cycle post-launch.
    • At the close of the year, a new blood draw tube was introduced for the collection of MaterniT21 samples, allowing for blood to be drawn directly at a doctor's office and shipped at ambient temperature.

"The accomplishments achieved in 2011, particularly in the last quarter with the launch and positive trajectory of the MaterniT21 LDT, are a reflection of the Company's dedication to achieving our mission to deliver genetic analysis solutions to improve patient care," said Harry F. Hixson, Jr, Ph.D., Chairman and CEO of Sequenom. "2011 was a year primarily dedicated to reaching our research and development goals, all of which we met.  In 2012, our p
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
2. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
3. SEQUENOM Announces Launch of MassARRAY Compact 96 System
4. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
5. Sequenom Appoints Two New Board Members
6. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
7. Sequenom to Present at Two Financial Conferences in March
8. Sequenom to Present at Two Financial Conferences in September
9. Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
10. Sequenom Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
11. Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today reported ... goals, other key objectives, and financial guidance.  Synageva,s ... at 4:30 p.m. EST to review the financial ... participate in today,s call by telephone, please dial ...
(Date:2/26/2015)... , Feb. 26, 2015 Protiviti ( www.protiviti.com ... version of the Governance Portal , designed to ... and compliance (GRC) tasks across multiple business units and ... to help customers better align their controls with the ... Commission ) requirements. In response to client feedback, Protiviti ...
(Date:2/26/2015)... February 26, 2015 The Movement for ... to support life extension technologies and awareness. The event ... Coordinated Time, on March 21st 2015, in a live ... , Eric Schulke, Founder of MILE, says, “Our lives ... urgency. The Movement for Indefinite Life Extension is raising ...
(Date:2/26/2015)... Feb. 26, 2015  NuGene International, Inc. ("NuGene") ... for skin and hair rejuvenation, has announced that ... of record for investor relations and strategic communications. ... distribution, sales and diversification strategies – and we ... prospective shareholders," stated Ali Kharazmi CEO of NuGene ...
Breaking Biology Technology:Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3
... Activated with Laser Light Beams, FORT LAUDERDALE, Fla., ... IMDS) a pioneer in laser,optical breast cancer imaging systems, ... That Bind to Cancer Cells" was,issued to IMDS by ... "We are very pleased to have been issued ...
... ORLANDO, FL, Nov. 5 /PRNewswire-FirstCall/ - ... today key scientific data,was presented in an ... at the American Heart Association Scientific Meetings. ... Increases,Serum Levels of ApoA-I and Improves High-Density ...
... Iceland, Nov. 5 deCODE genetics,(Nasdaq: DCGN ) ... September 30, 2007. A conference call to discuss the,quarter,s ... Tuesday, November 6, at 8:00am Eastern Standard Time/1pm GMT,(details ... 30, 2007 was $24.2 million,compared to $23.6 million for ...
Cached Biology Technology:Imaging Diagnostic Systems Expands Key Patent Coverage 2Imaging Diagnostic Systems Expands Key Patent Coverage 3Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting 2Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting 3deCODE genetics Announces Third Quarter 2007 Financial Results 2deCODE genetics Announces Third Quarter 2007 Financial Results 3deCODE genetics Announces Third Quarter 2007 Financial Results 4deCODE genetics Announces Third Quarter 2007 Financial Results 5deCODE genetics Announces Third Quarter 2007 Financial Results 6deCODE genetics Announces Third Quarter 2007 Financial Results 7deCODE genetics Announces Third Quarter 2007 Financial Results 8deCODE genetics Announces Third Quarter 2007 Financial Results 9
(Date:2/5/2015)... N.C. , Feb. 5, 2015  Marken is ... logistics company and has launched a new marketing campaign ... Logistics Organization (CLO).  The new campaign focuses on ... patient, protocol and shipments. The first headline ... , aligns Marken,s priorities with its client,s priorities. Marken ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
(Date:2/5/2015)... 28, 2015 New Market Research ... Segment Forecasts To 2020 has Been Added to GrandViewReseach.com ... is expected to reach USD 5.10 billion by 2020, ... Inc. IR cameras help identify the site of tissue ... witness surging demand in medical imaging applications. They have ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... not been faring well in recent decades, facing multiple threats ... referred to as the "rainforests of the Sea," coral reefs ... and contribute significantly to tourism and the fishing industry. A ... reefs: the damage caused by natural disasters such as an ...
... American Association for Cancer Research will host its Second AACR ... InterContinental San Francisco Hotel from Sept. 14-18, 2011. ... to share ideas and breakthroughs that will expedite the development ... "We are truly in an exciting period for ...
... JOLLA, CA - Oncologists have long sought a powerful "magic ... body so that they can be imaged and then destroyed. ... an agonist, needed to enter and accumulate in the cancerous ... shown in cancer patients that an investigational agent that sticks ...
Cached Biology News:Honduran earthquake of 2009 destroyed half of coral reefs of Belizean Barrier Reef lagoon 2Honduran earthquake of 2009 destroyed half of coral reefs of Belizean Barrier Reef lagoon 3First proof in patients of an improved 'magic bullet' for cancer detection and radio-therapy 2
...
22 x 50 mm; No. 1 thickness range: 0.13 to 0.17 mm, suitable for work in histology, cytology, urinalysis and microbiology, precleaned, store at room temperature ...
... 2.5%,Adenosine ... <0.1%,Cystathionine ... <0.1%,Glutathione ... ug/ml to 1 mg/ml,(0.26 M to 2.6 mM) Sensitivity: around 0.2 ...
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
Biology Products: